227 related articles for article (PubMed ID: 26276527)
21. MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma.
Kim BS; Kong DS; Seol HJ; Nam DH; Lee JI
J Neurooncol; 2017 Jul; 133(3):615-622. PubMed ID: 28536992
[TBL] [Abstract][Full Text] [Related]
22. Acid ceramidase confers radioresistance to glioblastoma cells.
Doan NB; Nguyen HS; Al-Gizawiy MM; Mueller WM; Sabbadini RA; Rand SD; Connelly JM; Chitambar CR; Schmainda KM; Mirza SP
Oncol Rep; 2017 Oct; 38(4):1932-1940. PubMed ID: 28765947
[TBL] [Abstract][Full Text] [Related]
23. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
24. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
McDonald MW; Shu HK; Curran WJ; Crocker IR
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
[TBL] [Abstract][Full Text] [Related]
25. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
Iuchi T; Hatano K; Kodama T; Sakaida T; Yokoi S; Kawasaki K; Hasegawa Y; Hara R
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):793-800. PubMed ID: 24495592
[TBL] [Abstract][Full Text] [Related]
26. Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.
Ellingson BM; Harris RJ; Woodworth DC; Leu K; Zaw O; Mason WP; Sahebjam S; Abrey LE; Aftab DT; Schwab GM; Hessel C; Lai A; Nghiemphu PL; Pope WB; Wen PY; Cloughesy TF
Neuro Oncol; 2017 Jan; 19(1):89-98. PubMed ID: 27580889
[TBL] [Abstract][Full Text] [Related]
27. Quantitative Assessment of Tumor Contact with Neurogenic Zones and Its Effects on Survival: Insights beyond Traditional Predictors.
Jung K; Kempter J; Prokop G; Herrmann T; Griessmair M; Kim SH; Delbridge C; Meyer B; Bernhardt D; Combs SE; Zimmer C; Wiestler B; Schmidt-Graf F; Metz MC
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730694
[TBL] [Abstract][Full Text] [Related]
28. A retrospective analysis of the risk factors affecting recurrence time in patients with recurrent glioblastoma.
Huang R; Wang T; Liao Z; Wang Z; Ye M; Zhou D; Xie H; Bai Y; Qiu Y; Liu Y
Ann Palliat Med; 2021 May; 10(5):5391-5399. PubMed ID: 34044551
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
[TBL] [Abstract][Full Text] [Related]
30. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.
Fitzek MM; Thornton AF; Rabinov JD; Lev MH; Pardo FS; Munzenrider JE; Okunieff P; Bussière M; Braun I; Hochberg FH; Hedley-Whyte ET; Liebsch NJ; Harsh GR
J Neurosurg; 1999 Aug; 91(2):251-60. PubMed ID: 10433313
[TBL] [Abstract][Full Text] [Related]
31. Quantitative Characterization of Tumor Proximity to Stem Cell Niches: Implications on Recurrence and Survival in GBM Patients.
Lao Y; Yu V; Pham A; Wang T; Cui J; Gallogly A; Chang E; Fan Z; Kaprealian T; Yang W; Sheng K
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1180-1188. PubMed ID: 33600888
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and prognostic significance of tumor involved with subventricular zone in pediatric glioblastoma: a 10-year experience in a single hospital.
Jiao Y; Wang M; Liu X; Wang J; Shou Y; Sun H
Childs Nerv Syst; 2022 Aug; 38(8):1469-1477. PubMed ID: 35474540
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
Straube C; Scherb H; Gempt J; Kirschke J; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
BMC Cancer; 2018 Jan; 18(1):15. PubMed ID: 29298660
[TBL] [Abstract][Full Text] [Related]
34. CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone.
Goffart N; Lombard A; Lallemand F; Kroonen J; Nassen J; Di Valentin E; Berendsen S; Dedobbeleer M; Willems E; Robe P; Bours V; Martin D; Martinive P; Maquet P; Rogister B
Neuro Oncol; 2017 Jan; 19(1):66-77. PubMed ID: 27370398
[TBL] [Abstract][Full Text] [Related]
35. Subventricular zone involvement in Glioblastoma - A proteomic evaluation and clinicoradiological correlation.
Gollapalli K; Ghantasala S; Kumar S; Srivastava R; Rapole S; Moiyadi A; Epari S; Srivastava S
Sci Rep; 2017 May; 7(1):1449. PubMed ID: 28469129
[TBL] [Abstract][Full Text] [Related]
36. Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy.
Holt DE; Bernard ME; Quan K; Clump DA; Engh JA; Burton SA; Heron DE
J Cancer Res Ther; 2016; 12(4):1243-1248. PubMed ID: 28169234
[TBL] [Abstract][Full Text] [Related]
37. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.
Thomas JG; Rao G; Kew Y; Prabhu SS
Neurosurg Focus; 2016 Oct; 41(4):E12. PubMed ID: 27690657
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy.
Aiken AH; Chang SM; Larson D; Butowski N; Cha S
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1340-6. PubMed ID: 18538496
[TBL] [Abstract][Full Text] [Related]
40. The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional role.
Digregorio M; Coppieters N; Lombard A; Lumapat PN; Scholtes F; Rogister B
Acta Neuropathol Commun; 2021 Apr; 9(1):59. PubMed ID: 33795013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
